Robust Gene Ranking via Unified Data Representation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing multivariate genetic data, such as microarray experiments, face challenges in producing stable and reliable gene rankings that are not significantly dependent on the selection of patients, leading to ambiguity and difficulty in drawing biologically relevant conclusions.
Innovation Solution
A computer-implemented method that computes a diagonal position matrix, a global weight matrix, and an expanded experimental list vector to represent gene expression data in a form allowing straightforward comparisons, using exchangeability scores and similarity coefficients to stabilize gene rankings and enable robust biological conclusions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional gene ranking methods are used to analyze multivariate genetic data, then the analysis can be performed with standard techniques, but the gene rankings become highly dependent on the specific sample selected, reducing reliability
Solution Approach 1:
The patent introduces an intermediary representation called a 'gene list' that mediates between the raw gene expression data and the final biological conclusions. This gene list serves as a stable intermediate structure that captures the essential information while being robust to sampling variations, thereby resolving the contradiction between ease of analysis and reliability of rankings.
Solution Approach 2:
The patent transforms the gene expression data by changing the parameters used to represent gene importance. Instead of relying on single-sample ranking positions, it uses aggregated measures across multiple samples and gene sets, fundamentally changing how gene significance is quantified and thereby improving reliability without sacrificing analytical accessibility.
2Adaptability or versatility
If multiple different patient samples are used to improve the generalizability of results, then the biological relevance may be improved, but the gene rankings become unstable and ambiguous
Solution Approach 1:
The patent merges information from multiple patient samples and multiple gene sets into a unified gene list representation. By combining data across different samples and aggregating gene importance scores, it achieves both generalizability (through multiple samples) and stability (through aggregation that smooths out sampling variations).
Solution Approach 2:
The patent performs preliminary aggregation and normalization of gene expression data across multiple samples before conducting the final analysis. This preliminary action of consolidating data from multiple sources into a stable gene list representation ensures that subsequent analyses benefit from both the generalizability of multiple samples and the stability of the aggregated representation.
3Adaptability or versatility
If different methods are used to represent results from different sources (e.g., ranked lists vs. unordered collections), then flexibility in data representation is achieved, but comparison between different data sources becomes difficult
Solution Approach 1:
The patent creates a universal gene list representation that can serve multiple functions: it can represent ranked gene lists, unordered gene collections, and hybrid representations. This single unified framework handles diverse data types from different sources, enabling flexible representation while simplifying comparisons through a common interface and metric system.
Data Source
Figure 1
Figure 2A~2B
Figure 3A~3B
AI summary
The present invention provides relatively robust comparison of bioinformatic data, such as gene expression data, by providing a computer-implemented method,a computer program product and a computer readable medium, that analyzes data according to the appended patent claims. The invention provides stability with respect to re-sampling of data.